Research summary ·
Early cardiovascular vulnerability after acute exacerbation of COPD: a time-windowed systematic review and evidence map.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This review looked at heart and blood vessel events after a flare-up of COPD. The team searched several databases up to 1 May 2026. It covered adult observational studies and follow-up analyses of trials. It also covered flare-ups of asthma or bronchiectasis. COPD was the main focus. The studies differed too much to pool. So the team made an evidence map by time window instead.
What they found
The search found 8027 records, and 34 were kept for review. They gave 110 effect estimates. Of these, 101 were about COPD. 57 fell within 30-day windows. Risk was higher early on than later, and this was consistent. This was clearest after severe or hospital-treated flare-ups. Signals were seen for coronary events, ischemic stroke and heart failure. They were also seen for AF or arrhythmia, heart death and combined severe outcomes. Asthma and bronchiectasis evidence was sparse.
What it means for patients
The paper says a severe COPD flare-up marks a short window of heart risk. It says this holds for severe or hospital-treated flare-ups. It says this was clearest in the first month. It says the map shows when recovery should be handled as heart and lung care.
Why it is not certain yet
The studies differed in design, end points, severity definitions and risk windows. So the paper gives no single pooled risk figure. Evidence on asthma and bronchiectasis was thin and exploratory. Studies like these show links, not cause.
Source
Early cardiovascular vulnerability after acute exacerbation of COPD: a time-windowed systematic review and evidence map.
PubMed · PMID 42800650We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Bronchiectasis publications